HF
NAUT icon

HRT Financial’s Nautilus Biotechnolgy NAUT Stock Holding History

HRT Financial’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$675K Buy
361,073
+295,819
+453% +$781K ﹤0.01% 2424
2026
Q1 		$253K Buy
+65,254
New +$160K ﹤0.01% 3027
2022
Q4 		– Sell
-25,278
Closed -$53K – 2898
2022
Q3 		$53K Sell
25,278
-36,047
-59% -$90.7K ﹤0.01% 2440
2022
Q2 		$164K Sell
61,325
-49,833
-45% -$185K ﹤0.01% 2308
2022
Q1 		$482K Buy
+111,158
New +$456K ﹤0.01% 1869
2021
Q3 		– Sell
-42,859
Closed -$432K – 3601
2021
Q2 		$432K Buy
42,859
+12,953
+43% +$140K ﹤0.01% 1904
2021
Q1 		$412K Buy
29,906
+185
+0.6% +$2.56K ﹤0.01% 1929
2020
Q4 		$322K Sell
29,721
-4,060
-12% -$42.8K 0.01% 1247
2020
Q3 		$362K Buy
+33,781
New +$360K 0.01% 1037

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

HRT Financial's NAUT Position: Q2 2026 in Review

HRT Financial increased its Nautilus Biotechnolgy (NAUT) stake by 453% in Q2 2026, buying an estimated $781K and bringing the position to 361,073 shares worth $675K. The position accounts for ﹤0.01% of the portfolio, ranked #2424.

HRT Financial first reported a position in NAUT in Q3 2020 and has held it in 9 quarters since. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • HRT Financial held 361,073 shares of Nautilus Biotechnolgy worth $675K as of Q2 2026.
  • HRT Financial bought 295,819 Nautilus Biotechnolgy shares in Q2 2026, an estimated $781K.
  • Nautilus Biotechnolgy made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2424 holding.
  • HRT Financial first reported a position in Nautilus Biotechnolgy in Q3 2020 and has held it in 9 quarters since.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.